Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
about
Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone DToward the treatment and prevention of Alzheimer's disease: rational strategies and recent progressRole of the axonal initial segment in psychiatric disorders: function, dysfunction, and interventionHeterotrimeric Go protein links Wnt-Frizzled signaling with ankyrins to regulate the neuronal microtubule cytoskeletonStatins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway.Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosisAmyloid-β plaques disrupt axon initial segments.Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.Aging Does Not Affect Axon Initial Segment Structure and Somatic Localization of Tau Protein in Hippocampal Neurons of Fischer 344 Rats.Effects of ankyrin 3 gene risk variants on brain structures in patients with bipolar disorder and healthy subjects.Ankyrin 3: genetic association with bipolar disorder and relevance to disease pathophysiologyAntibodies to TRIM46 are associated with paraneoplastic neurological syndromes.AnkG hemizygous mice present cognitive impairment and elevated anxiety/depressive-like traits associated with decreased expression of GABA receptors and postsynaptic density protein.Phosphorylation, Dephosphorylation, and Multiprotein Assemblies Regulate Dynamic Behavior of Neuronal Cytoskeleton: A Mini-Review
P2860
Q30355359-9244DEA6-CBA0-4CE3-B4E1-59DBAFF624FCQ30419992-9008B39E-8688-4FE4-822D-5B04946A0E82Q34071914-81E181C5-E36C-4017-96AE-0215317101EFQ34348735-DDF1AC9B-83F7-4003-87B2-B026F9419AA3Q36235102-1DA5BE96-25CD-49E7-9574-228BFDAB694EQ36409002-D7208331-02CD-4816-A140-83BF08978081Q36927721-70CBDC73-3CE9-4C80-B3E4-FD9E888F5506Q38184618-68627ED6-81DE-4DCE-84AB-4AEE65EB0C40Q38635680-A8C6CB6B-1B94-48FF-87D8-D139C2AC0027Q39528056-3630B34F-150A-43E3-AAFC-1D858778530EQ41391566-C7640AB6-52D9-4E5C-B328-4D379DDD5CFFQ41509158-1EACE337-A726-4A09-8FC4-545854C848C8Q47793954-71997B94-9E2D-47A2-92EF-B26EDC900C6EQ57817550-70E5DB13-F727-4183-BAD0-51B7DA783C5A
P2860
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
@en
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
@nl
type
label
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
@en
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
@nl
prefLabel
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
@en
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
@nl
P2093
P2860
P50
P356
P1433
P1476
Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice
@en
P2093
C Bernreuther
J McAfoose
M T Ferretti
R M Nitsch
P2860
P2888
P304
P356
10.1038/MP.2012.70
P407
P577
2012-06-12T00:00:00Z
P6179
1022900670